Related references
Note: Only part of the references are listed.Structural progression in axial spondyloarthritis
Krystel Aouad et al.
JOINT BONE SPINE (2020)
Can Imaging Be a Proxy for Remission in Axial Spondyloarthritis?
Krystel Aouad et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Treat to Target in Axial Spondyloarthritis Pros, Cons, and Future Directions
Jean W. Liew et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Treat-to-target in axial spondyloarthritis: gold standard or fools' gold?
Pedro M. Machado et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Is There a Role for MRI to Establish Treatment Indications and Effectively Monitor Response in Patients with Axial Spondyloarthritis?
Monica Schwartzman et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2019)
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M. Ward et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors
Sara Monti et al.
MODERN RHEUMATOLOGY (2018)
New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice
Sayam Dubash et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2018)
Challenges and Advances in Targeting Remission in Axial Spondyloarthritis
Xenofon Baraliakos et al.
JOURNAL OF RHEUMATOLOGY (2018)
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors
Andrea Y. Shimabuco et al.
ADVANCES IN RHEUMATOLOGY (2018)
Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis
Ennio Giulio Favalli et al.
ARTHRITIS CARE & RESEARCH (2017)
Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?
Barbara Neerinckx et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort
Victoria Navarro-Compan et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Mariagrazia Lorenzin et al.
BMC MUSCULOSKELETAL DISORDERS (2015)
The burden of non-radiographic axial spondyloarthritis
Annelies Boonen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography
X. Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
MRI-detected subclinical joint inflammation is associated with radiographic progression
A. Krabben et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Association of Bone Edema with the Progression of Bone Erosions Quantified by Hand Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis in Remission
Maria Pilar Lisbona et al.
JOURNAL OF RHEUMATOLOGY (2014)
Treat to Target in Rheumatoid Arthritis
Daniel H. Solomon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study
U. Kiltz et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor
Pedro Machado et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Radiographic progression in ankylosing spondylitis/axial spondyloarthritis: how fast and how clinically meaningful?
Denis Poddubnyy et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
Pedro Machado et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis
A. K. Brown et al.
ARTHRITIS AND RHEUMATISM (2008)
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission - Evidence from an imaging study may explain structural progression
A. K. Brown et al.
ARTHRITIS AND RHEUMATISM (2006)
Spondyloarthritis research consortium of Canada magnetic resonance Imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis
WP Maksymowych et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Share Paper
